InvestorsHub Logo
Followers 3
Posts 1891
Boards Moderated 0
Alias Born 11/28/2005

Re: powerwalker post# 28200

Tuesday, 06/06/2017 10:12:05 AM

Tuesday, June 06, 2017 10:12:05 AM

Post# of 30990
powerwalker, you are wrong.

Archer's Nilvad might be targeting beta-amyloid, but Rock Creek's anatabine definitely is not about beta-amyloid.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.